Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2012-07-18

FDA Approved: DEFEROXAMINE — Supplemental Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

FDA approved a supplemental application for Deferoxamine (Deferoxamine Mesylate) from Fresenius Kabi USA, LLC, likely involving changes to labeling or formulati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Deferoxamine (deferoxamine)

Snippet

SUPPL AP for DEFEROXAMINE (DEFEROXAMINE MESYLATE)